GB Sciences' Chief Science Officer Featured on the Cover of the Marijuana Business Magazine
Summary
In the October 2019 Issue of Marijuana Business Magazine, Dr. Andrea Small-Howard Explains Why GBS is Well Positioned in New Market Segments as the Medical Cannabis Industry Evolves LAS VEGAS, Oct. 9, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) is featured in the October 2019 edition of the Marijuana Business Magazine. Despite the growth of adult use markets in the US, GB Sciences is one of several companies that sees the evolution of the medical marijuana industry as an exciting opportunity. "On the wellness side, we are convinced that novel delivery systems, such as oral thin films, will allow convenient and more efficacious dosing of cannabis compounds for customers who want the therapeutic benefits of these cannabis-based ingredients." Although our current patent applications cover formulations addressing over 60 medical conditions, we have identified three or four that are destined for the US FDA route, while many others will be developed for the health and wellness markets. GB Sciences, Inc. (OTCQB: GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development.